A share price of Surgery Partners Inc [SGRY] is currently trading at $22.37, up 0.18%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SGRY shares have gain 0.68% over the last week, with a monthly amount glided 0.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, BofA Securities started tracking the stock with Buy rating on December 16, 2024, and set its price target to $30. On October 14, 2024, UBS initiated with a Buy rating and assigned a price target of $38 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Sector Weight rating. Macquarie initiated its recommendation with a Outperform and recommended $31 as its price target on June 28, 2024. Barclays started tracking with a Equal Weight rating for this stock on March 06, 2024, and assigned it a price target of $35. In a note dated November 14, 2023, TD Cowen upgraded an Outperform rating on this stock and revised its target price from $39 to $35.
Surgery Partners Inc experienced fluctuations in its stock price throughout the past year between $18.87 and $33.97. Currently, Wall Street analysts expect the stock to reach $40.8 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $22.37 at the most recent close of the market. An investor can expect a potential return of 82.39% based on the average SGRY price forecast.
Analyzing the SGRY fundamentals
Trailing Twelve Months sales for Surgery Partners Inc [NASDAQ:SGRY] were 3.17B which represents 8.17% growth. Gross Profit Margin for this corporation currently stands at 0.23% with Operating Profit Margin at 0.11%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.1 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.18 points at the first support level, and at 21.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.54, and for the 2nd resistance point, it is at 22.70.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Surgery Partners Inc [NASDAQ:SGRY] is 1.89. In addition, the Quick Ratio stands at 1.73 and the Cash Ratio stands at 0.4. Considering the valuation of this stock, the price to sales ratio is 0.90, the price to book ratio is 1.65.
Transactions by insiders
Recent insider trading involved Baldock Jennifer, Chief Admin & Dev Officer, that happened on Mar 14 ’25 when 612.0 shares were sold. Chief Human Resources Officer, Burkhalter Danielle completed a deal on Mar 14 ’25 to sell 74.0 shares. Meanwhile, American Group President Webb William Trenton sold 138.0 shares on Mar 14 ’25.
